Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Green Med Solution (BGMS) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Bio Green Med Solution (BGMS) over the last 17 years, with Q3 2025 value amounting to $8.2 million.

  • Bio Green Med Solution's Liabilities and Shareholders Equity rose 5160.75% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.4 million, marking a year-over-year decrease of 2856.94%. This contributed to the annual value of $4.1 million for FY2024, which is 5350.37% down from last year.
  • Bio Green Med Solution's Liabilities and Shareholders Equity amounted to $8.2 million in Q3 2025, which was up 5160.75% from $4.4 million recorded in Q2 2025.
  • In the past 5 years, Bio Green Med Solution's Liabilities and Shareholders Equity registered a high of $51.8 million during Q1 2021, and its lowest value of $3.7 million during Q1 2025.
  • Over the past 5 years, Bio Green Med Solution's median Liabilities and Shareholders Equity value was $17.0 million (recorded in 2023), while the average stood at $22.3 million.
  • Per our database at Business Quant, Bio Green Med Solution's Liabilities and Shareholders Equity surged by 29899.13% in 2021 and then crashed by 7273.21% in 2024.
  • Bio Green Med Solution's Liabilities and Shareholders Equity (Quarter) stood at $43.1 million in 2021, then plummeted by 34.97% to $28.0 million in 2022, then crashed by 68.61% to $8.8 million in 2023, then crashed by 53.5% to $4.1 million in 2024, then skyrocketed by 99.27% to $8.2 million in 2025.
  • Its Liabilities and Shareholders Equity was $8.2 million in Q3 2025, compared to $4.4 million in Q2 2025 and $3.7 million in Q1 2025.